David R. McAvoy's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 1,113 Ordinary Shares done at an average price of $18.9 . Disclosure was reported to the exchange on Sept. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 18.86 per share. | 05 Sep 2025 | 1,113 | 13,027 (0%) | 0% | 18.9 | 20,988 | Ordinary Shares |
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 56,603 | 56,603 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 16,741 | 50,223 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 16,741 | 16,741 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 04 Mar 2025 | 3,150 | 13,591 (0%) | 0% | 15.7 | 49,564 | Ordinary Shares |
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 04 Mar 2025 | 1,677 | 11,914 (0%) | 0% | 15.9 | 26,686 | Ordinary Shares |
| Teva Pharmaceutical Industries | David R. McAvoy | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 66,964 | 66,964 | - | - | Restricted Share Units | |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | Gen Counsel, CCO, & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 23 Jul 2021 | 18,124 | 128,879 (1%) | 0% | 0.7 | 12,138 | Common Stock |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 17 May 2021 | 18,622 | 110,755 (1%) | 0% | 0.8 | 14,898 | Common Stock |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 17 May 2021 | 7,980 | 13,980 (0%) | 0% | 0.8 | 6,384 | Common Stock |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 0 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 100,883 (1%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 8,750 | 92,133 (0%) | 0% | 1.1 | 9,975 | Common Stock |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 18 Sep 2020 | 16,526 | 75,883 (0%) | 0% | 0.8 | 13,713 | Common Stock |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 18 Sep 2020 | 6,000 | 6,000 (0%) | 0% | 0.8 | 5,039 | Common Stock |
| Fresh Tracks Therapeutics Inc | David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 350,000 | 350,000 | - | - | Stock Option (right to buy) |